CHICAGO – The Blue Cross Blue Shield Association has partnered with Onduo, a diabetes management company created by Sanofi and Alphabet’s Verily, on a pilot program that will provide eligible members with access to personalized and convenient diabetes care.
The pilot is designed to measure Type 2 diabetes outcomes, including those relating to clinical improvement, cost and member experience.
“Blue Cross and Blue Shield companies have a long history of bringing locally tailored, innovative programs to the communities we serve,” said Jody Voss, vice president of development, innovation and the group purchasing organization for BCBSA, in a statement. “We are pleased to be able to continue this tradition by partnering with Onduo on a new diabetes management program that will help eligible members better manage their Type 2 diabetes.”
The Onduo platform integrates hardware and software to provide people with access to personalized, convenient diabetes care. Participating BCBS members will be matched to the clinically appropriate interventions, including wirelessly-connected continuous glucose monitoring devices, lifestyle support, medication review and a team of Onduo health care experts. In collaboration with local BCBS network doctors, the program aims to provide care and support to members when and where they want it.
The Onduo platform will extend physicians’ support by providing guidance and continuous support to members between doctor visits.
“Onduo’s goal is to increase access to solid, evidence-based interventions in a personalized manner,” said Josh Riff, CEO of Onduo, in a statement. “Managing diabetes is a 24/7 job that we want to make easier for members.”
Pilots will begin in the first quarter of 2018 in Arkansas, Georgia and South Carolina with select BCBS members who are eligible.